Phosphorylation of tau and α-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer’s disease, and in Parkinson’s disease and related α-synucleinopathies

• Published in: Neuroscience 2008-04, Vol.152 (4), p.913-923
• Main Authors: Muntané, G, Dalfó, E, Martinez, A, Ferrer, I
• Format: Article
• Language: English
• Subjects: A53T transgenic mouse; Aged; Aged, 80 and over; alpha-Synuclein - metabolism; Alzheimer Disease - pathology; Alzheimer’s disease; Biological and medical sciences; Biopsy - methods; Case-Control Studies; Cyclin-Dependent Kinase 5 - metabolism; Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases; dementia with Lewy bodies; Female; Frontal Bone - pathology; Fundamental and applied biological sciences. Psychology; Glycogen Synthase Kinase 3 - metabolism; Glycogen Synthase Kinase 3 beta; Humans; Male; Medical sciences; Microscopy, Electron, Transmission - methods; Middle Aged; Neurology; Parkinson Disease - pathology; Parkinson’s disease; Phosphorylation; Serine - metabolism; Synapses - metabolism; Synapses - ultrastructure; Synaptophysin - metabolism; tau; tau Proteins - metabolism; Vertebrates: nervous system and sense organs; α-synuclein
• ISSN: 0306-4522; 1873-7544
• DOI: 10.1016/j.neuroscience.2008.01.030

Abstract Phosphorylation of tau and phosphorylation of α-synuclein are crucial abnormalities in Alzheimer’s disease (AD) and α-synucleinopathies (Parkinson’s disease: PD, and dementia with Lewy bodies: DLB), respectively. The presence and distribution of phospho-tau were examined by sub-fractionation, gel electrophoresis and Western blotting in the frontal cortex of cases with AD at different stages of disease progression, PD, DLB pure form and common form, and in age-matched controls. Phospho-tauSer396 has been found in synaptic-enriched fractions in AD frontal cortex at entorhinal/transentorhinal, limbic and neocortical stages, thus indicating early tau phosphorylation at the synapses in AD before the occurrence of neurofibrillary tangles in the frontal cortex. Phospho-tauSer396 is also found in synaptic-enriched fractions in the frontal cortex in PD and DLB pure and common forms, thus indicating increased tau phosphorylation at the synapses in these α-synucleinopathies. Densitometric studies show between 20% and 40% phospho-tauSer396, in relation with tau-13, in synaptic-enriched fractions of the frontal cortex in AD stages I–III, and in PD and DLB. The percentage reaches about 95% in AD stage V and DLB common form. Yet tau phosphorylation characteristic of neurofibrillary tangles, as revealed with the AT8 antibody, is found in the synaptic fractions of the frontal cortex only at advanced stages of AD. Increased phosphorylated α-synucleinSer129 levels are observed in the synaptic-enriched fractions of the frontal cortex in PD and DLB pure and common forms, and in advanced stages of AD. Since tau-hyperphosphorylation has implications in microtubule assembly, and phosphorylation of α-synuclein at Ser129 favors α-synuclein aggregation, it can be suggested that synapses are targets of abnormal tau and α-synuclein phosphorylation in both groups of diseases. Tau phosphorylation at Ser396 has also been found in synaptic-enriched fractions in 12-month-old transgenic mice bearing the A53T α-synuclein mutation.